Does microalbuminuria predict diabetic nephropathy?

被引:123
作者
Tabaei, BP
Al-Kassab, AS
Ilag, LL
Zawacki, CM
Herman, WH
机构
[1] Univ Michigan, Med Ctr, Div Endocrinol, Taubman Ctr 3920,Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
关键词
D O I
10.2337/diacare.24.9.1560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To describe risk factors associated with microalbuminuria (MA) in subjects with diabetes. investigate the predictive value of MA as a marker of risk for diabetic nephropathy (DN), and define risk factors associated with the development and progression of MA. RESEARCH DESIGN AND METHODS - We conducted a prospective longitudinal study of 23 diabetic subjects with persistent MA and 209 diabetic subjects without KA who attended diabetes clinics at the University of Michigan Medical Center in 1989 and 1990. Both ps were examined at baseline and after 7 years. At baseline, urinary albumin-to-creatinine groups ratios were studied in random, first morning, and 24-h urine samples. At follow-up, a 12-h overnight urine sample was collected and analyzed for albumin and creatinine. At baseline, MA was defined by at least two separate urine specimens with albumin-to-creatinine ratios between 30 and 299 mug albumin per milligram of creatinine. RESULTS - MA regressed in 56% of subjects with baseline MA without systematic application of corrective measures and developed in 16% of subjects without baseline MA. The predictive value positive of MA as a marker of risk for DN was 43%, and the predictive value negative,was 77%,. In the combined cohort, the incidence and progression of MA were significantly associated with poor glycemic control and duration of diabetes between 10 and 14 years. CONCLUSIONS - MA may not be as sensitive and specific a predictor of DN as previously suggested. Other markers of risk, for DN are needed for optimal clinical management.
引用
收藏
页码:1560 / 1566
页数:7
相关论文
共 36 条
  • [1] THE PREDICTIVE VALUE OF MICROALBUMINURIA IN IDDM - A 5-YEAR FOLLOW-UP-STUDY
    ALMDAL, T
    NORGAARD, K
    FELDTRASMUSSEN, B
    DECKERT, T
    [J]. DIABETES CARE, 1994, 17 (02) : 120 - 125
  • [2] Microalbuminuria in patients with NIDDM: An overview
    Alzaid, AA
    [J]. DIABETES CARE, 1996, 19 (01) : 79 - 89
  • [3] *AM DIAB ASS, 2000, DIABETES CARE S1, V23, pS69
  • [4] [Anonymous], BIOSTATISTICAL METHO
  • [5] Glycemic control and prognosis in type I diabetic patients with microalbuminuria
    Bojestig, M
    Arnqvist, HJ
    Karlberg, BE
    Ludvigsson, J
    [J]. DIABETES CARE, 1996, 19 (04) : 313 - 317
  • [6] Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects
    Bruno, G
    CavalloPerin, P
    Bargero, G
    Borra, M
    Calvi, V
    DErrico, N
    Deambrogio, P
    Pagano, G
    [J]. DIABETES CARE, 1996, 19 (01) : 43 - 47
  • [7] Factors associated with microalbuminuria in Type 1 diabetes mellitus:: a cross-sectional study
    Campos-Pastor, MM
    Escobar-Jiménez, F
    Mezquita, P
    Herrera-Pombo, JL
    Hawkins-Carranza, F
    Luna, JD
    Azriel, S
    Serraclara, A
    Rigopoulos, M
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 48 (01) : 43 - 49
  • [8] The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient?
    Caramori, ML
    Fioretto, P
    Mauer, M
    [J]. DIABETES, 2000, 49 (09) : 1399 - 1408
  • [9] Close CF, 1999, DIABETIC MED, V16, P918
  • [10] SOME METHODS FOR STRENGTHENING THE COMMON X2 TESTS
    COCHRAN, WG
    [J]. BIOMETRICS, 1954, 10 (04) : 417 - 451